Skip to main content
. 2020 Apr 3;14:304. doi: 10.3389/fnins.2020.00304

TABLE 1.

Demographic and clinical characteristics of anti-LGI1 encephalitis patients.

Age, mean (SD) 55.9 (10.6) years
Sex 11 male, 3 female
Modified Rankin Scale scorea, mean (SD) 2.2 (0.8)
Time from symptom onset to diagnosis, mean (SD) 3.4 (2.3) months
Mini-Mental State Examination (MMSE), mean (SD) 22.1(5.9)
Montreal Cognitive Assessment (MoCA), mean (SD) 18.3(5.5)
Symptom
Memory impairment 10/14 (71%)
Seizure 11/14 (79%)
Faciobrachial dystonic seizures 4/14 (29%)
Mental and behavioral abnormalities 4/14 (29%)
Cerebrospinal fluid
Glucose (mmol/L), mean (SD) 4.6 (1.2)
Chlorine (mmol/L), mean (SD) 121 (5.6)
Proteinb (g/L), mean (SD) 0.38 (0.17)
Lactic acidc (mmol/L), mean (SD) 2.2 (0.3)
Antibodies to LGI1
Serum (positive) 14/14 (100%)
Cerebrospinal fluid (positive) 10/14 (71%)

aThe criteria of the modified Rankin Scale (mRS) score can be described as: 0 – No symptoms at all. 1 – No significant disability despite symptoms; able to carry out all usual duties and activities. 2 – Slight disability; unable to carry out all previous activities, but able to look after own affairs without assistance. 3 – Moderate disability; requiring some help, but able to walk without assistance. 4 – Moderately severe disability; unable to walk and attend to bodily needs without assistance. 5 – Severe disability; bedridden, incontinent and requiring constant nursing care and attention. bCSF Protein normal values: <0.45 g/L. cCSF lactic acid normal values: 1.2–2.1 mmol/L.